子宫内膜癌盆腔前哨淋巴结转移的患病率与大小
该研究纳入2014年6月至2024年1月在一所大学医院接受机器人手术并检测盆腔前哨淋巴结的连续子宫局限性子宫内膜癌患者,采用吲哚菁绿示踪的解剖学算法并对所有前哨淋巴结行超分期和免疫组化。1045例中174例(16.6%)存在前哨淋巴结转移,术前 presumed 低级别子宫内膜样子宫1A期患者转移风险为9.8%,低级别癌中孤立肿瘤细胞比例为47.4%,高于高级别或非子宫内膜样癌的19.2%(p<.0001)。
要点
- 1045例中前哨淋巴结转移174例(16.6%)。
- 术前 presumed 低级别子宫内膜样子宫1A期转移风险9.8%。
- 低级别癌孤立肿瘤细胞47.4% vs 高风险组织学19.2%(p<.0001)。
核心结论
- 这项大型人群研究通过持续应用前哨淋巴结算法,提供了子宫内膜癌各风险组前哨淋巴结转移风险和大小的详细资料。
- 术前 presumed 低级别子宫1A期子宫内膜样子宫内膜癌的转移风险为9.8%,促使在该亚组中检测前哨淋巴结。
- 高风险组织学类型中前哨淋巴结孤立肿瘤细胞的比例显著更低。
研究设计与样本
- 研究纳入2014年6月至2024年1月在一所大学医院接受机器人手术并检测盆腔前哨淋巴结的连续子宫局限性子宫内膜癌女性。
- 采用以吲哚菁绿为示踪剂的解剖学算法,对所有前哨淋巴结行超分期和免疫组化。
- 分析前哨淋巴结转移的患病率和大小与术前及术后组织学类型和肌层浸润估计的关系。
主要发现
- 1045例中前哨淋巴结转移174例(16.6%),其中低级别子宫内膜样癌759/1045(72.6%)、高级别子宫内膜样癌79/1045(7.6%)、非子宫内膜样癌207/1045(19.8%)。
- 术前 presumed 低级别子宫内膜样子宫1A期患者前哨淋巴结转移比例为9.8%,最终组织学低级别1A期为6.4%。
- 高级别子宫内膜样子宫1B期和非子宫内膜样子宫1B期患者前哨淋巴结转移比例分别为58.3%和47.8%。
- 低级别子宫内膜癌中孤立肿瘤细胞为45/95(47.4%),高级别或非子宫内膜样癌为15/78(19.2%),p<.0001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM OF THE STUDY: To assess the association of prevalence and size of pelvic sentinel node (SLN) metastases with risk factors in endometrial cancer (EC). PATIENTS AND METHODS: Between June 2014 and January 2024 consecutive women with a uterine confined EC undergoing robotic surgery including detection of pelvic SLNs at a University Hospital were included. An anatomically based algorithm utilizing Indocyanine green (ICG) as tracer was adhered to. Ultrastaging and immunohistochemistry (IHC) was applied on all SLNs. The prevalence and size of SLN metastases was assessed with regards to pre- and postoperative histologic types and myometrial invasion estimates. RESULTS: Of 1101 included women 72.6 % (759/1045) had low-grade, 7.6 % (79/1045) high-grade endometroid cancer and 19.8 % (207/1045) non-endometroid cancer. SLN-metastases were present in 174/1045 (16.6 %) women; 9.8 % of preoperatively presumed low-grade endometroid uterine stage 1A (6.4 % of low-grade stage 1A at final histology) and in 58.3 % and 47.8 % respectively in women with high-grade endometroid and non-endometroid uterine stage 1B cancer. In low-grade EC 45/95 (47.4 %) had only isolated tumor cells (ITC) in SLNs compared with 15/78 (19.2 %) in high-grade or non-endometroid cancer (p < .0001) CONCLUSION: This large population-based study, applying a consequent SLN-algorithm over time, provides important detailed information on the risk for, and size of, SLN metastases within risk groups of EC. The 9.8 % risk for metastases in women with presumed low grade uterine stage 1A endometrioid EC motivates detection of SLNs within this subgroup. The proportion of ITCs in SLNs was significantly lower in higher risk histologies.
引用
- Bollino M, Geppert B, Lönnerfors C, et al. Prevalence and size of pelvic sentinel lymph node metastases in endometrial cancer. Eur J Cancer. 2024. PMID: 39142212. doi:10.1016/j.ejca.2024.114265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。